Health Care/Hospital
Health On Cloud Showcases Innovative Healthcare Solutions at the Korea-LAC Trade and Innovation Forum, Accelerating Expansion into Latin America
SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Health On Cloud (HOC) is impactingColombia's healthcare sector through the use of digital innovations in a pilot project funded by the Inter-American Development Bank (IDB). This initiative is scheduled to expand toMexico and Brazil in the first ha...
2024-12-02 22:00
1573
United Imaging Debuts Breakthrough AI-Powered Innovations at RSNA 2024
HOUSTON, Dec. 2, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2024. This year's exhibit will include several new product debuts in the fields of magnetic resona...
2024-12-02 22:00
1008
ACROBiosystems' US Innovation Lab Earns ISO 17025 Accreditation to Accelerate Biomedicine Discovery and Development
NEWARK, Del., Dec. 2, 2024 /PRNewswire/ -- ACROBiosystems' US Innovation Lab has recently achieved ISO/IEC 17025 accreditation for its Surface Plasmon Resonance (SPR) analytical service, ensuring that results from this service is globally recognized and trusted for its precision and consistency. ...
2024-12-02 22:00
1195
MeditWave 2024 in Porto Brings Together Global Experts to Shape the Future of Digital Dental Solutions
PORTO, Portugal, Dec. 2, 2024 /PRNewswire/ -- On November 9, Medit, a global leader in digital dentistry solutions, hosted its two-day MeditWave 2024 in Porto, Portugal. This dynamic gathering of dental professionals from around the world fostered valuable exchanges and showcased the latest innova...
2024-12-02 22:00
1093
Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in improving cancer detection, radiologist workload, and screening efficiency SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...
2024-12-02 22:00
1455
'Green City' Video Exhibition Sees Wide Participation from Chinese, American Students
CHONGQING, China, Dec. 2, 2024 /PRNewswire/ -- A news report from iChongqing -
Since the launch of the "Green City • Discover My City" Original Short Video
Exhibition, the initiative has inspired creativity from middle and primary
school students inChina and the United States.
2024-12-02 20:48
1312
European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New Study on Bioregenerative Blueprint for Athletic Longevity
KOTA KINABALU, Malaysia, Dec. 2, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, has unveiled a groundbreaking study led by renowned expert Prof.Mike Chan on the physiological challenges aging athletes face. The analysis explores how age ...
2024-12-02 16:30
2420
Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu, Unveiling its "AI Agent Solution"
CHENGDU, China, Dec. 2, 2024 /PRNewswire/ -- On November 22, 2024, Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, hosted the "Data and AI: Decoding Digital Engagement" summit in Chengdu, bringing together key representatives from leading Internet...
2024-12-02 15:21
1354
Witsbb Launches Major New Product! Elderberry Yeast β-glucan Drink Boosts Health for Sensitive Children
SYDNEY, Dec. 2, 2024 /PRNewswire/ -- Recently, Witsbb, a pioneer in "allergy-free" nutrition, has launched its latest product – the Elderberry Yeast β-glucan drink. As an immune-boosting nutritional product specifically developed for children aged 6 months to 12 years, the Elderberry Yeast β-gluc...
2024-12-02 12:52
1476
MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research
* The implementation of MGI Tech's next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, contributing to disease prevention, and personalizing medical treatments. * A team of specialists...
2024-12-02 11:16
1129
George Clinical Welcomes Tony Proctor as Chief Financial Officer
SINGAPORE, Dec. 2, 2024 /PRNewswire/ -- George Clinical, a leading global clinical research organisation, is pleased to announce the appointment ofTony Proctor, C.P.A., as Chief Financial Officer (CFO). With over 25 years of financial leadership experience, Tony brings a wealth of expertise in dr...
2024-12-02 08:15
1489
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong
SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Gover...
2024-12-02 07:40
1642
When ancient cures meet smart tech: Level up your health
BEIJING, Dec. 1, 2024 /PRNewswire/ -- This is a report from China.org.cn.   Join presenter Jason Dane Castleton at the Health and Wellness pavilion of the second China International Supply Chain Expo, where innovations from traditional medicine to genetic technology are transform...
2024-12-01 19:34
2411
CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China
* CBC Group and Mubadala acquire UCB's mature neurology and allergy business inChina for US$680 million. * New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry. * Strategic acquisition under CBC's buyout strategy exp...
2024-11-30 09:00
5559
Young International Scientists Say Tech Cooperation Creates Strong Bond
BEIJING, Nov. 29, 2024 /PRNewswire/ -- For Muhammad Salman Hameed, a Pakistani researcher, his six years of experience inChina have been highly rewarding. He has not only refined his research techniques and expanded his professional network, but also built cross-cultural relationships that have e...
2024-11-30 00:12
3101
BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech
CHENGDU, China, Nov. 29, 2024 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), a leading global pharmaceutical enterprise, today announced its acquisition of the intelligent platform of AIX Inc. (NASDAQ: AIFU) ("AIX") valued at1 billion RMB (approximately $140 million). The ...
2024-11-29 23:58
4790
AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead?
HONG KONG, Nov. 29, 2024 /PRNewswire/ -- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims services. Recently, the company has been gradually pushing for an intelligent and diversified transformation, aiming to capture growth opportunities in the AI insurance and ...
2024-11-29 23:11
4429
What does Taiwan mean to China?
BEIJING, Nov. 29, 2024 /PRNewswire/ -- A news report from China.org.cn:   What does Taiwan mean to China? The Taiwan issue is of great significance and encompasses multiple dimensions, thus it is regarded as a focus of China-U.S. competition. Why is the Taiwan issue the first...
2024-11-29 22:00
2999
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transitioning to oral Contezolid tablets for the treatment of adult patients with complex sk...
2024-11-29 22:00
2554
Minghui Pharmaceutical Announces Positive Topline Results from Phase Ⅲ Trial of MH004 (Tofacitinib Etocomil) Ointment in Mild to Moderate Atopic Dermatitis
SHANGHAI, Nov. 29, 2024 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive topline results from its phase Ⅲ trial of MH004 (tofacitinib etocomil) ointment 1.0%, a twic...
2024-11-29 20:31
2713
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 291 media titles]
2025-01-14 21:00
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20749
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6566
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
6070
Boqii Announces ADS Ratio Change
2025-01-11 05:30
5127
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
5111
